European Association for the Study of Diabetes Annual Meeting

Healio brings you the highlights from the European Association for the Study of Diabetes Annual Meeting. Refer back to this page often for the latest news from EASD, perspectives and interviews with leading researchers and clinicians, and to review archives of past meetings.

Meeting News Coverage

CKD risk score predicted microalbuminuria in type 2 diabetes

August 20, 2013
A predefined chronic kidney disease risk score using proteomic measurements accurately predicted the development of persistent microalbuminuria…
Meeting News Coverage

CANVAS: Canagliflozin effective as add-on therapy in type 2 diabetes

October 10, 2012
Patients with type 2 diabetes who are at elevated risk for cardiovascular disease experienced significant reductions in blood glucose when using…
Meeting News Coverage

Empagliflozin lowered systolic BP, regardless of weight, HbA1c

Endocrine Today, November 2012
Patients with type 2 diabetes experienced significant reductions in systolic blood pressure after treatment with empagliflozin that were…
Meeting News Coverage

Diabetes increases death rate among U.K. youth

Endocrine Today, November 2012
Research presented at the 48th Annual Meeting of the European Association for the Study of Diabetes in Berlin demonstrates that women in the U.K…
Meeting News Coverage

President of EASD calls for improved device registration, monitoring in Europe

Endocrine Today, November 2012
European diabetes device regulation is in need of “radical change,” according to president of the European Association for the Study of …
Meeting News Coverage

Investigational DPP-IV inhibitor at various doses reduced HbA1c in type 2 diabetes

October 3, 2012
Phase 2b results have demonstrated that an investigational, once-weekly DPP-IV inhibitor significantly lowered HbA1c, compared with placebo, among…
Meeting News Coverage

Injection-free exenatide well tolerated, effective at higher doses

Endocrine Today, November 2012
As part of a 24-week phase 2 study to select a specific dosing regimen for a phase 3 clinical program, researchers found that higher doses of…
Meeting News Coverage

Four studies find linagliptin effective as monotherapy, add-on in adults with type 2 diabetes

October 2, 2012
Linagliptin administered alone or in combination with other diabetes medications, and as an add-on to basal insulin therapy, lowered HbA1c in…
Meeting News Coverage

Splitting high-dose insulin, injecting in two sites improved blood glucose control

Endocrine Today, November 2011
EASD 47th Annual Meeting LISBON — Splitting high-dose insulin and injecting it in two sites may lead to significant improvements in glycemic…
Meeting News Coverage

Experts join forces to learn more about link between obesity, type 2 diabetes

Endocrine Today, November 2011
EASD 47th Annual Meeting LISBON — The European Association for the Study of Diabetes, American Diabetes Association and the Endocrine Society are…